The European urinary incontinence therapeutics market is valued at 11.77 billion in 2025. The market is witnessing a major transformation towards a personalized and directed mode of treatment. This trend was analyzed by our Senior Research Analyst, Deepa Pandey curated the report. Her analysis is useful to pharma companies, healthcare providers, urology specialists, and investors in the industry in comparing the situation with one another and in making strategic decisions.